Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Winthrop University Hospital |
---|---|
Information provided by: | Winthrop University Hospital |
ClinicalTrials.gov Identifier: | NCT00914550 |
The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the results of these blood tests, they may be able to stop some of the antibiotic medications that they may have given to the patients. The study is designed, so that on a randomized basis (50/50 chance) the results from measuring Procalcitonin will be given to the patients' doctor. When the doctor receives these results, he/she may use this information, along with other information, to decide whether to continue antibiotic therapy.
Condition | Intervention |
---|---|
Pneumonia Radiographic Lung Infiltrates |
Other: Procalcitonin level, caregiver informed |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia |
Serum Procalcitonin
Estimated Enrollment: | 100 |
Study Start Date: | June 2009 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
Procalcitonin level, caregiver informed
Procalcitonin level for patients with lung infiltrates:caregivers know/ do not know results
|
Other: Procalcitonin level, caregiver informed
Procalcitonin levels will be measured and known by investigator, only 1/2 of the patients' caregivers will know the results of serial Procalcitonin levels. We will analyze the rate of antibiotic discontinuation for the two arms
|
To evaluate the usefulness of serum Procalcitonin level measured to guide the antibiotic treatment of patients with radiographic lung infiltrates.The subjects involved in the study will be divided in two arms ,study arm where the caregivers will know the result of Procalcitonin level and they can change /withheld the antibiotic for the subjects.In other arm only investigators will know the Procalcitonin level. We expect to enroll 100 patients.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Adults admitted to Winthrop University Hospital with Lung Infiltrates undergoing antibiotic therapy
Inclusion Criteria:
Exclusion Criteria:
Contact: Michael Niederman, MD | 516-663-4637 | mniederman@winthrop.org |
Contact: Shweta Upadhyay, MD | 516-663-2588 | SUpadhyay@winthrop.org |
United States, New York | |
Winthrop-University Hospital | |
Mineola, New York, United States, 11501 |
Principal Investigator: | Michael Niederman, MD | Winthrop University Hospital |
Responsible Party: | Winthrop-University Hospital ( Michael Niederman, MD ) |
Study ID Numbers: | 107003-3 |
Study First Received: | June 4, 2009 |
Last Updated: | June 4, 2009 |
ClinicalTrials.gov Identifier: | NCT00914550 History of Changes |
Health Authority: | United States: Institutional Review Board |
Pneumonia Lung Infiltrates Antibiotic discontinuation De-escalation therapy |
Anti-Bacterial Agents Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases Pneumonia |
Respiratory Tract Infections Respiratory Tract Diseases Lung Diseases Pneumonia |